Sugimoto Toshiro, Soumura Mariko, Danno Kiichiro, Kaji Kenzo, Kondo Miki, Hirata Kunio, Nakazawa Jun, Uzu Takashi, Nishio Yoshihiko, Kashiwagi Atsunori
Department of Medicine, Shiga University of Medical Science, Seta, Otsu, 520-2192, Japan.
Mod Rheumatol. 2006;16(5):309-11. doi: 10.1007/s10165-006-0504-4.
We have encountered a 68-year-old Japanese woman with limited cutaneous systemic sclerosis who developed de novo onset of accelerated hypertension and renal dysfunction; thus we diagnosed scleroderma renal crisis. Anticentromere antibody alone was identified, and not anti-DNA topoisomerase I antibody, anti-RNA polymerase antibodies, anti-Th/To antibodies, or antiribonucleoprotein antibodies, even with use of immunoprecipitation assay. She was successfully treated with angiotensin-converting enzyme inhibitor. This case, scleroderma renal crisis with detection of anticentromere antibody, is thought to be extremely uncommon.
